Melanoma

MD IQ

Conference Coverage

Pediatric cancers are on the rise

PITTSBURGH – CDC investigators detected a significant increase in pediatric cancers from 2001 through 2014, although the reasons for the rise are...

From the Journals

Checkpoint inhibitors get to patients quickly

Within about 4 months of FDA approval of PD-1 inhibitors, the majority of patients with melanoma, NSCLC, and RCC began receiving these agents.

Pages